Arbutus Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,014 | $179,126 | $1,051 | $529 |
Gross Profit | 1,014 | 179,115 | 1,040 | 518 |
EBITDA | -5,114 | 169,723 | -3,727 | -7,708 |
EBIT | -5,125 | 169,712 | -3,738 | -7,719 |
Net Income | -5,143 | 169,695 | -3,756 | -7,742 |
Net Change In Cash | 1,014 | 179,126 | 1,051 | 529 |
Free Cash Flow | -6,018 | -8,110 | -4,680 | -5,817 |
Cash | 19,171 | 23,706 | 18,008 | 22,408 |
Basic Shares | 197,470 | 195,214 | 191,599 | 191,778 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $14,083 | $6,171 | $18,141 | $39,019 |
Gross Profit | 13,720 | 6,171 | 18,141 | 39,019 |
EBITDA | -33,041 | -68,403 | -70,986 | -61,859 |
EBIT | -33,404 | -69,783 | -72,390 | -63,286 |
Net Income | -33,501 | -69,920 | -72,849 | -69,456 |
Net Change In Cash | 14,083 | 6,171 | 18,141 | 39,019 |
Cost of Revenue | -78,484 | |||
Free Cash Flow | -39,637 | -65,032 | -86,944 | -35,868 |
Cash | 18,008 | 36,330 | 26,285 | 30,776 |
Basic Shares | 191,599 | 185,608 | 165,960 | 150,939 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.03 |
2026-03-31 | $1.19 |
2025-12-31 | -$0.01 |
2025-09-30 | -$0.06 |